Complexes of Copper and Iron with Pyridoxamine, Ascorbic Acid, and a Model Amadori Compound: Exploring Pyridoxamine’s Secondary Antioxidant Activity
Open Access
- 1 February 2021
- journal article
- research article
- Published by MDPI AG in Antioxidants
- Vol. 10 (2) , 208
Abstract
The thermodynamic stability of 11 complexes of Cu(II) and 26 complexes of Fe(III) is studied, comprising the ligands pyridoxamine (PM), ascorbic acid (ASC), and a model Amadori compound (AMD). In addition, the secondary antioxidant activity of PM is analyzed when chelating both Cu(II) and Fe(III), relative to the rate constant of the first step of the Haber-Weiss cycle, in the presence of the superoxide radical anion ) or ascorbate (ASC−). Calculations are performed at the M05(SMD)/6-311+G(d,p) level of theory. The aqueous environment is modeled by making use of the SMD solvation method in all calculations. This level of theory accurately reproduces the experimental data available. When put in perspective with the stability of various complexes of aminoguanidine (AG) (which we have previously studied), the following stability trends can be found for the Cu(II) and Fe(III) complexes, respectively: ASC < AG < AMD < PM and AG < ASC < AMD < PM. The most stable complex of Cu(II) with PM (with two bidentate ligands) presents a value of −35.8 kcal/mol, whereas the Fe(III) complex with the highest stability (with three bidentate ligands) possesses a of −58.9 kcal/mol. These complexes can significantly reduce the rate constant of the first step of the Haber-Weiss cycle with both and ASC−. In the case of the copper-containing reaction, the rates are reduced up to 9.70 × 103 and 4.09 × 1013 times, respectively. With iron, the rates become 1.78 × 103 and 4.45 × 1015 times smaller, respectively. Thus, PM presents significant secondary antioxidant activity since it is able to inhibit the production of ·OH radicals. This work concludes a series of studies on secondary antioxidant activity and allows potentially new glycation inhibitors to be investigated and compared relative to both PM and AG.
Keywords
Funding Information
- Natural Sciences and Engineering Research Council of Canada (Discovery Grant)
This publication has 47 references indexed in Scilit:
- Theoretical calculations of stability constants and pKa values of metal complexes in solution: application to pyridoxamine–copper(ii) complexes and their biological implications in AGE inhibitionPhysical Chemistry Chemical Physics, 2013
- Pyridorin in Type 2 Diabetic NephropathyJournal of the American Society of Nephrology, 2012
- DFT Studies on Schiff Base Formation of Vitamin B6 Analogues. Reaction between a Pyridoxamine-Analogue and Carbonyl CompoundsThe Journal of Physical Chemistry A, 2010
- Universal Solvation Model Based on Solute Electron Density and on a Continuum Model of the Solvent Defined by the Bulk Dielectric Constant and Atomic Surface TensionsThe Journal of Physical Chemistry B, 2009
- Maillard reaction products in tissue proteins: New products and new perspectivesAmino Acids, 2003
- Pimagedine: a novel therapy for diabetic nephropathyExpert Opinion on Investigational Drugs, 2002
- Complexes of Vitamin B6. 23. Interaction of Some Tertiary Ligating Amino Acids with the Binary Complexes of Ni(II) or Cu(II) and PyridoxamineJournal of Chemical & Engineering Data, 1999
- Influence of advanced glycation end-products and AGE-inhibitors on nucleation-dependent polymerization of β-amyloid peptideBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1997
- Kinetics of the Competitive Degradation of Deoxyribose and Other Molecules by Hydroxyl Radicals Produced by the Fenton Reaction in the Presence of Ascorbic AcidFree Radical Research, 1995
- Ascorbate Autoxidation in the Presence of Iron and Copper ChelatesFree Radical Research Communications, 1986